PL436726A1 - Sposób wytwarzania nanonośników poli(D,L laktydowyh) stabilizowanych surfaktyną oraz nanonośniki wytworzone tym sposobem - Google Patents
Sposób wytwarzania nanonośników poli(D,L laktydowyh) stabilizowanych surfaktyną oraz nanonośniki wytworzone tym sposobemInfo
- Publication number
- PL436726A1 PL436726A1 PL436726A PL43672621A PL436726A1 PL 436726 A1 PL436726 A1 PL 436726A1 PL 436726 A PL436726 A PL 436726A PL 43672621 A PL43672621 A PL 43672621A PL 436726 A1 PL436726 A1 PL 436726A1
- Authority
- PL
- Poland
- Prior art keywords
- surfactin
- lactide
- nanocarriers
- prepared
- preparing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229920001244 Poly(D,L-lactide) Polymers 0.000 title abstract 3
- 239000002539 nanocarrier Substances 0.000 title 2
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 abstract 3
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 abstract 3
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 238000003756 stirring Methods 0.000 abstract 2
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 238000001704 evaporation Methods 0.000 abstract 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 abstract 1
- 239000012074 organic phase Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 239000012798 spherical particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
- C08J3/21—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase
- C08J3/215—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase at least one additive being also premixed with a liquid phase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
Przedmiotem wynalazku jest sposób otrzymywania polimerowych nośników (D,L laktydowych) stabilizowanych surfaktyną, charakteryzujący się tym, że ma następujące etapy: a) rozpuszczenie poli(D,L laktydu) w rozpuszczalniku organicznym; b) prowadzenie precypitacji międzyfazowej poprzez wkraplanie fazy organicznej wytworzonej w etapie a) do wodnego roztworu surfaktyny przez 1-5 minut przy ciągłym mieszaniu fazy wodnej, przy czym surfaktyna w roztworze wodnym stanowi surfaktynę w formie kwasu karboksylowego lub soli sodowej; c) mieszanie aż do wytrącenia się polimeru; d) odparowanie rozpuszczalnika organicznego. Kolejnym przedmiotem wynalazku są polimerowe nośniki poli(D,L laktydowe) stabilizowane surfaktyną wytworzone sposobem według wynalazku, charakteryzujące się tym, że stanowią sferyczne cząstki o średnicy hydrodynamicznej wynoszącej od 125 do 200 i współczynniku polidyspersyjności PDI˂0.15.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL436726A PL245026B1 (pl) | 2021-01-21 | 2021-01-21 | Sposób wytwarzania nanonośników poli(D,L laktydowych) stabilizowanych surfaktyną oraz nanonośniki wytworzone tym sposobem |
PCT/IB2022/050506 WO2022157678A1 (en) | 2021-01-21 | 2022-01-21 | Method of obtaining surfactin-stabilised poly(d,l-lactide) nanocarriers and nanocarriers produced with this method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL436726A PL245026B1 (pl) | 2021-01-21 | 2021-01-21 | Sposób wytwarzania nanonośników poli(D,L laktydowych) stabilizowanych surfaktyną oraz nanonośniki wytworzone tym sposobem |
Publications (2)
Publication Number | Publication Date |
---|---|
PL436726A1 true PL436726A1 (pl) | 2022-07-25 |
PL245026B1 PL245026B1 (pl) | 2024-04-22 |
Family
ID=80780754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL436726A PL245026B1 (pl) | 2021-01-21 | 2021-01-21 | Sposób wytwarzania nanonośników poli(D,L laktydowych) stabilizowanych surfaktyną oraz nanonośniki wytworzone tym sposobem |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL245026B1 (pl) |
WO (1) | WO2022157678A1 (pl) |
-
2021
- 2021-01-21 PL PL436726A patent/PL245026B1/pl unknown
-
2022
- 2022-01-21 WO PCT/IB2022/050506 patent/WO2022157678A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022157678A1 (en) | 2022-07-28 |
PL245026B1 (pl) | 2024-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4981696A (en) | Polylactide compositions | |
CN103304775B (zh) | 环氧微胶囊及其制备方法 | |
CA1337516C (en) | Polylactide compositions | |
Tham et al. | Surface engineered poly (lactic acid)(PLA) microspheres by chemical treatment for drug delivery system | |
Feng et al. | Effects of drug and polymer molecular weight on drug release from PLGA‐m PEG microspheres | |
Qiao et al. | Silk fibroin-coated PLGA dimpled microspheres for retarded release of simvastatin | |
CN101678113A (zh) | 缓释性的含有带负电荷基团的低分子药物的纳米粒子 | |
CN106117570B (zh) | 一种负载聚酰胺-胺树状分子的海藻酸钠抗菌水凝胶及其制备方法和应用 | |
PL436726A1 (pl) | Sposób wytwarzania nanonośników poli(D,L laktydowyh) stabilizowanych surfaktyną oraz nanonośniki wytworzone tym sposobem | |
Ferrari et al. | Tunable PLGA‐Based Nanoparticles Synthesized Through Free‐Radical Polymerization | |
CN103205081A (zh) | 一种温度敏感性壳聚糖基聚电解质复合胶束的制备方法 | |
Demina et al. | Chitosan‐g‐Polyester Microspheres: Effect of Length and Composition of Grafted Chains | |
Ding et al. | Synthesis and characterization of bovine serum albumin-loaded microspheres based on star-shaped PLLA with a xylitol core and their drug release behaviors | |
Levato et al. | Preparation of biodegradable polylactide microparticles via a biocompatible procedure | |
WO2012142328A2 (en) | Polymer microsphere compositions for localized delivery of therapeutic agents | |
Dutta et al. | Tailoring sub‐micron PLGA particle release profiles via centrifugal fractioning | |
Zhang et al. | Controlled release of bovine serum albumin from electrospun fibrous membranes via an improved emulsion-core technique | |
JP2018533417A5 (pl) | ||
Portilla‐Arias et al. | Biodegradable Nanoparticles of Partially Methylated Fungal Poly (β‐l‐malic acid) as a Novel Protein Delivery Carrier | |
Tan et al. | Preparation, characterization, and drug‐release properties of PEG‐DA‐based copolymer hydrogel microspheres | |
Lu et al. | Preparation of poly (propylene‐co‐γ‐butyrolactone carbonate) and release profiles of drug‐loaded microcapsules | |
KR20180019800A (ko) | 세포전달을 위한 다공성 마이크로스피어 및 이의 제조방법 | |
CN101007868A (zh) | 一种生物降解性纳米胶束控释制剂的制备方法 | |
Demina et al. | Solid-state modified polylactides for processing of 3D materials with enhanced biocompatibility | |
CN102836131A (zh) | 丁丙诺啡皮下注射用缓释微球制剂及其制备方法 |